Chief, Peds Hem-Onc at MassGeneral Hosp. for Children
Pediatric Hematology & Oncology
Dr. Howard J. Weinstein, MD
|
|
Give Review
Doctor Howard J. Weinstein, MD is an expert in the field of Pediatric Hematology & Oncology. He attended University of Maryland School of Medicine. University of Maryland School of Medicine is ranked 37/52 in Research/PrimaryCare. He over the years received 5 awards: "America's Top Doctors", "Boston Magazine", "America's Top Doctors for Cancer", "Boston Herald" and "Super Doctor". Howard J. Weinstein has written publications. He has 16 publications published with PubMed. The lastest paper is: 'Relapse After Treatment of Pediatric Hodgkin Lymphoma: Outcome and Role of Surveillance After End of Therapy.'
Publications
- Relapse After Treatment of Pediatric Hodgkin Lymphoma: Outcome and Role of Surveillance After End of Therapy.
- Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group S...
- Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults, with high proliferation index and no BCL2 rearrangement.
- Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo ...
- The evolving standard of care for hodgkin lymphoma.
- Pathology quiz case 2. Diagnosis: follicular lymphoma (FL), grade 3, pediatric type.
- Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.
- Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia.
- Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in ...
- Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
- Rituximab therapy for multisystem autoimmune diseases in pediatric patients.
- Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 19-200. A five-day-old girl with leukocytosis and a worsening rash from ...
- Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation.
- VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial.
- Pediatric non-Hodgkin's lymphoma: clinical and biologic prognostic factors and risk allocation.
Schools
University of Maryland At Baltimore Professional Schools
Massachusetts General Hospital
Children39s HospDana Farber
Nih Bcrc Baltimore MD
Doctors Specialties
- Pediatrics
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
- America's Top Doctors for Cancer
- Boston Herald
- Super Doctor
Education
-
University of Maryland -
Massachusetts General Hospital -
University of Maryland School of Medicine
Hospital
-
Newton-Wellesley Hospital -
Massachusetts General Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Jeffrey Rubens, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suzanne Shusterman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarabeth Broder-Fingert, MD |
|
|
Dr. Curtis L. Nordgaard, MD |
|
|
Dr. Christopher D. Adrian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Athena Xifaras, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie A. Silberman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie A. Bartholomew, MD
This Doctor is OpenDoctor Recommended.
|